The last eight survivors of 80 workers accidentally exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) during production of herbicides based on trichlorophenoxyacetic acid in 1965-1967 in a chemical factory were followed. All were men, mean age 72.4 AE 1.3 years. Their current median TCDD blood level was 112 (46-390) pg/g lipids. Neurological examination revealed central nervous system impairment in all individuals and signs of polyneuropathy in 87.5%, which was confirmed by a nerve conduction study (NCS) 
The history of intoxication of about 80 Czech workers due to occupational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in herbicide production (butylester of trichlorophenoxyacetic acid) in a chemical factory in Central Bohemia is more than 50 years old. There was no accident, but due to a higher temperature and pressure in production in the years [1965] [1966] [1967] [1968] , an uncontrolled decomposition reaction occurred and TCDD originated as a by-product. More than 55 persons developed chloracne and other symptoms of intoxication [1] .
The problem of exposure to herbicides derived from chlorophenols and their production by-products or combustion products and consequent health effects have been described by several authors from other countries. Perhaps the most commonly recognized phenoxyherbicides preparations are the 2,4,5-trichloro-phenoxyacetic acid (2,4,5-T) and 2,4,-dichlorophenoxyacetic acid (2,4,-D) for the control of broad-leaved plants species in forestry and agriculture. During production, not only TCDD but also other dioxin-like toxic by-products originated. For example, in the late 1930s, all commercial grades of chlorophenol preparations contained some amount of toxic contaminants, including TCDD [2] . German phenoxyherbicides and chlorophenols production workers were exposed in 1953 during an accident in BASF at Ludwigshaven, and during uncontrolled production to by-products in other factories [3] [4] [5] . In the late 1960s, pesticide applicators involved in ground-level spraying were exposed to toxic dimer contaminants in several countries, including Scandinavia [6, 7] and New Zealand [8] . A large accident involving the area around Seveso, Italy, occurred in 1976 [9] . Both the population in Vietnam [10] and military personnel who served in the U.S. armed forces in Vietnam from 1965 to 1971, when TCDD-contaminated Agent Orange was widely sprayed as an herbicide and defoliant (Operation Ranch Hand) have still elevated plasma TCDD levels, compared to the unexposed population [11] . However, the group of Czech chemical workers belongs to the most exposed groups of individuals [12] . The TCDD concentration in the blood of 13 exposed workers could be first measured in the year 1996, that is about 30 years after the exposure, and the median level of 210 (14-760) pg/g fat confirmed a very high level of exposure [1] . Two patients had first measurement in 2003. The levels are shown in table 1. There was a significant positive correlation of TCDD with neuropsychological variables in the year 1996
Author for correspondence: Daniela Pelclova, Department of Occupational Medicine, First Medical Faculty and General University Hospital in Prague, Charles University, Na Bojisti 1, 120 00, Prague 2, Czech Republic (e-mail daniela@pelclova.cz). on one hand, and blood cholesterol and triglycerides on the other. Significant correlations were seen between TCDD, disturbances of lipid metabolism and/or nervous system lesions throughout the years [12, 13] . In the years 2004, 2008 and 2010, many former workers still complained of psychological disorders, especially fatigue, headache, sleeping disturbances and internal disorders [14] [15] [16] [17] . The objective of this study was to determine the incidence and development of nervous system disturbances related to occupational exposure to 2,3,7,8-TCDD in the last eight patients surviving the incident for 50 years.
Methods
Eight men were assessed during a follow-up examination with the focus on neurological and cognitive changes caused by TCDD. The results in 2016 were compared with the findings during the previous examinations in 2004 and 2010. The patients gave written consent for the examination which was a part of follow-up visit concerning their occupational disease.
Polychlorobenzodioxins (PCDDs) and polychlorodibenzofurans (PCDFs) levels were analysed by isotope dilution high-resolution gas chromatography (HRGC) and mass spectrometry after clean-up of the silica and carbon columns.
Neurological status. Neurological status was evaluated through a standardized clinical examination, which included an evaluation of reflexes, motor and sensory functions of the cranial nerves, the upper and lower extremities, station and gait. Diminished sensation to touch and pain in a stocking-glove distribution, diminished vibration sense, bilateral loss of ankle and/or knee jerks or bilateral diminished deep tendon reflexes in the lower as compared to the upper extremities were considered clinical signs of peripheral neuropathy.
Nerve conduction studies (NCS). Nerve conduction velocity was measured in motor and sensory fibres of the median, ulnar, tibial and sural nerves using Neuromatic 2000, Keypoint (Dantec, Czech Republic) and TruTrace 4 (Alien Technik, Czech Republic) devices.
Electroencephalography (EEG). Electroencephalography (EEG) was recorded with a 21-channel digital machine (Walter Graphtek, Czech Republic) on awake patients in a supine position with closed eyes. Silver/silver chloride scalp electrodes were placed according to the international 10-20 system, with a ground electrode at the forehead position (Fp z ). Electrode impedance was kept below 5 kΩ. The bandwidth of amplifiers was 0.5-70 Hz. The examination included a resting record of 15 min., followed by 4 min. of hyperventilation and finally by intermittent photic stimulation with flash frequencies of 1-30 Hz.
Visual-evoked potentials (VEP) examination. Visual-evoked potentials (VEP) examination was performed using a two-channel TruTrace 4 device (Alien Technik, Czech Republic). A monocular full-field checkerboard stimulation was used with a pattern reversal frequency of 1.5 Hz, stimulus field size 12 0 9 9 0 , check size 1 0 , mean luminance of TV screen 20 cd/m 2 and 69% contrast between light and dark squares. Bioelectrical activity was recorded from O z to F z derivation. The bandwidth of the amplifier was 1-100 Hz; sweep duration was 300 msec. Two hundred responses were averaged. Two criteria of abnormality based on 95% reference range were used: (i) latency of the P1 wave longer than 117 msec. and (ii) side-to-side difference of the P1 wave latencies greater than 6 msec.
The Lanthony desaturated 15-hue panel (L-D15-d) was used to test colour discrimination. The test was administered under a 'northern daylight' fluorescent lamp with a colour temperature of approximately 5000 0 K, giving a luminance of 1200 lx on the work plane. The left and right eyes were tested separately. People who wore glasses used them during the examination. None of the individuals wore contact lenses, coloured lenses or tinted glasses. The individuals were given as much time as they needed to complete the test. The results were expressed in two ways: (i) quantitatively, as Bowman's colour confusion index (CCI), which is calculated as the ratio of the actual to the ideal total colour difference score. The value of the CCI in an individual with errorless performance is 1.0. The worse the colour discrimination, the higher the value of the CCI; (ii) qualitatively, on a specially designed template, by drawing lines connecting numbers of consecutive caps. TCDD-2,3,7,8-tetrachlorodibenzo-p-dioxin; N -normal result, A -abnormal result (1 point); CNS -central nervous system; PNS -peripheral nervous system; NCS -nerve conduction study; EEG -electroencephalography; VEP -visual-evoked potential; SPECT -Single-photon emission computer tomography; r -Pearson correlation coefficient. *p-values for significance of the differences in TCDD concentration between individuals with abnormal and normal results of the test; average number of abnormal results in 2016 and 2004 was compared and was significantly higher in 2016. 1 On the level of significance p = 0.019).
Based on the major confusion axis, the dyschromatopsias were categorized into three types according to Verriest [18] . Toxicityacquired dyschromatopsias usually impair blue-yellow discrimination (type III dyschromatopsia), while congenital dyschromatopsias are usually of type I with impairment on the green-red axis. Type II is of a mixed character.
Single-photon emission computer tomography (SPECT). Perfusion brain SPECT was performed after an intravenous injection of 700-800 MBq 99 m
Tc-HMPAO (99 m technetium hexamethylpropyleneamine oxime, that is exametazime -CERETEC TM , GE Healthcare) with a twohead rotating gamma camera (Infinia GE, USA) under standard conditions [19] . Assessment of 99m Tc-HMPAO distribution was performed visually and semi-quantitatively by quantitative comparison (of the count of impulses of the radiopharmaceutical) using Segami NeuroGam 'voxel by voxel' software. Comparison with an age-matched normal population using this programme is based on stereotactic normalization [20] and statistical subtraction using a discrimination level of AE2.0 standard deviations. The figures present the pathological findings, that is hypoperfusion, or hyperfixation of the radiopharmaceutical in the identical brain region, the severity of which is seen in the colour scale (based on the number of standard deviations). Subtraction analysis was performed after image count normalization to the cerebellum and the whole brain. Anatomical identification was based on Brodmann areas [21] .
Neuropsychological examination. Neuropsychological examination included a standardized neuropsychological assessment based on the Uniform Data Set (UDS) neuropsychological test battery [22] and an evaluation of the level of depressive symptoms [23] and instrumental activities of daily living [24] for the differentiation of mild and major neurocognitive disorders.
Examination also included carbohydrate-deficient transferrin (CDT) (as an index of the past 1-2 weeks' alcohol consumption) measured by high-performance liquid chromatography (HPLC).
Statistical analysis. Statistical evaluations were carried out using the following basic statistical tests: test of normality of distribution, arithmetic mean, standard deviation, median, modus and Student's, two sample assuming unequal variances (equal means), test and confidence intervals. Statistical significance was set at p < 0.05. Associations between pairs of quantitative variables were measured by Pearson's and Spearman's correlation coefficients.
Results
The mean age of the eight surviving male workers was 72. 4 
Visual-evoked potentials was abnormal in two of 16 examined eyes, borderline in six eyes and normal in eight eyes. The abnormality is likely to be due to the severe impairment of visual acuity. When evaluating at the level of eight individual patients, a bilateral or at least unilateral VEP abnormality was found in six of them. There had been no progression since 2010.
Lanthony D15-d test was examined in all eight patients. No patient had normal colour vision. Patient No. 6 suffered from congenital dyschromatopsia; therefore, he had to be excluded from further analysis. As shown in table 2, the remaining seven patients showed results compatible with an acquired dyschromatopsia on the blue-yellow axis of type II-III according to Verriest [18] . As compared to 2010, two patients had improvement and five had worsened. On a group level, the global measure of colour vision impairment, that is CCI, slightly increased from the mean value of 1.52 AE 0.37 in 2010 to 1.73 AE 0.41 in 2016; however, the change was not statistically significant (p = 0.441).
Single-photon emission computer tomography showed focal reduction in perfusion in various brain locations in both hemispheres in all patients, as shown in table 1 fig. 1 .
None of the findings presented in table 1 were related to alcohol consumption, measured by CDT level.
All the results of these methods are shown in table 1, and the total number of abnormalities in 2016 is presented. The number of the abnormal results from examinations in the same patients in 2004 is included. There was a significant elevation of the number of pathological results within the 12 years, documenting a progression of the findings.
Most individuals complained of psychological problems and two of them (patients Nos. 4 and 6) used antidepressants. The UDS neuropsychological test battery was divided into domains of cognitive functioning, and the results are shown in table 4.
Most positive impairments were seen in the Trail Making Test (TMT) evaluating processing speed and set shifting, which correlated with mean CCI (p < 0.05). TMT is a classical executive dysfunction measure which is very sensitive to brain injury or CNS toxic involvement [26] . There was no correlation with TCDD blood level. One test only, Boston Naming Test (BNT-30), correlated with CDT % (p < 0.05); however, this test was positive in patients Nos. 7 and 8, that is in individuals with the lowest TCDD plasma levels (mean 56 pg/g fat).
Discussion
The effects of TCDD exposure persist for decades due to very long presence of TCDD in the body fat, and there is no antidote able to efficiently eliminate it from the human body [27, 28] . With the TCDD level back-calculated to the time of exposure, using the physiologically based half-life and assuming first-order kinetics [29] , our cohort ranks among the most severely exposed groups. Using the extrapolation from the Ranch-Hand veterans, where the veteran with the highest level had about 80 pg/g lipids measured 30 years later, was similar to our patient No. 8 (with 30-year level of 74 pg/g fat in 1996). The estimated level to the time of exposure was approximately 35,000 [30] . Accordingly, in our most exposed patient No. 1 (with a 30-year level of 760 pg/g fat), the zero level could reach 350,000 -more pg/g fat. The evaluation is approximate and depends also on the body fat content. Because it slightly increased with time, the estimated TCDD zero level could be even higher.
Other congeners should not be neglected, especially 2,3,4,7,8-PeCDF (TEF 0.3) that may have played the key role at the higher TEQ level. The median level 25 pg/g lipids in patients was two times, compared with the wives of the patients with median 12 pg/g lipids. In 1996, its median level was 56 (19- Most patients showed neurological and neuropsychological impairments in previous follow-up examinations [1, [12] [13] [14] [15] [16] [17] . As can be seen, further deterioration from 2010 to 2016 was seen in several findings in the last follow-up.
Nerve conduction study confirmed polyneuropathic changes in 75% of patients, who had a mean TCDD plasma level of 220 AE 140 pg/g fat; two patients without polyneuropathy had mean 56 AE 127 pg/g fat (the difference was not significant, p = 0.15). In 2010, only 63.6% of individuals had NCS impairments. Toxic polyneuropathy is one of the recognized toxic effects of TCDD exposure, seen for example in the early studies of people exposed to TCDD in the Seveso accident [32] . Also, in experimental studies, rats developed a dosedependent significant slowing of motor and sensory nerve conduction velocities, and histological signs of polyneuropathy were found [33] . EEG does not seem typical for chronic TCDD exposure. Thirty years after exposure, in 1996, EEG was still abnormal in 71% of these individuals, but in 2004 it normalized in all eight individuals and it remains like this 50 years after exposure. We may infer that EEG abnormality reflects acute/ subacute reversible changes in brain functioning, which are not related to vascular impairment found by SPECT because this, in contrast, showed a tendency to worsen over time.
The proportion of VEP impairment has slowly increased in this group of individuals from 2004 [14] as can be seen in table 1.
Our study has a very long history; therefore, using SPECT is relatively new in our follow-up studies of TCDD-exposed individuals. Local perfusion impairments were first seen in the year 2004 in 93% of a total of 15 patients and both in 2008 and 2010 in 91% of a total of 11 patients [15, 17] . In all eight patients followed for the longest time, focal reduction in In our first study in 1996, significant correlations were found between several neuropsychological variables and the plasma level of TCDD on one hand, and lipid plasma levels on the other [1] . In the following years, hypolipidaemic treatment was started and, in 2016, seven patients were using this medication and two had psychiatric medication. This may contribute to the explanation of why recent neuropsychological findings do not show correlations with TCDD level. As can be seen in table 4, the cognitive impairment was found especially in the processing speed. Obviously, the neuropsychological examination is not able to distinguish the sequelae of the poisoning in the brain due to TCDD from other causes such as neurodegenerative disease. However, we may suggest that the cognitive deficits were caused rather by a long-term, deleterious influence of poisoning on the brain because the impairment is selective and detectable especially in tests measuring the speed of processing (TMT, Digit Symbol) rather than explicit memory. This finding can be interconnected with SPECT which indicated areas of the expressive hypoperfusion in the superior parietal lobule (Brodmann's Area 7; fig. 1 ) and is concordant with previous evidence of activation of this area in TMT during functional magnetic resonance imaging (fMRI) [34] . Brodmann's Area 7 receives a great deal of visual input and sensory information from hands, concurrently TMT and Digit Symbol are both dependent on visual attention and graphomotor skills [35] . Experimentally, TCDD can damage nervous tissue by oxidative stress associated with the AhR-mediated induction of CYP1B1 isoenzyme [36] [37] [38] [39] , and the elevation of oxidative stress markers was also found in our patients [17] .
Our study has a case series design, describing the results of comprehensive examinations targeted at the nervous system in eight patients with chronic poisoning which happened about 50 years ago. The main limitation of our study is the small number of the individuals examined, who were the last survivors available for the study. The value of this study, on the other hand, lies in the long-term follow-up of these patients and evolution of the results using the same methods.
Conclusions
The group of Czech chemical workers belongs to the most exposed groups of individuals. Fifty years after exposure, the median TCDD level is still 112 pg/g blood lipids, that is about 10 times higher in comparison with the general population, which confirms the long persistence of TCDD in the human body.
Single-photon emission computer tomography of the brain appears to be the most important objective method, which showed focal reduction of perfusion in various brain locations in 100% of patients and worsening in six patients. Neurological examination revealed clinical CNS impairment in 100% of individuals, and signs of polyneuropathy were confirmed with NCS in 87.5% of individuals. Also, Lanthony test and VEP demonstrated a gradual tendency of deterioration. EEG with normal findings in all individuals does not seem supportive to prove the damage. None of these examinations were associated with alcohol consumption, as measured by CDT. The mean number of impairments significantly increased from 3.50 AE From the UDS neuropsychological test battery, the TMT evaluating processing speed showed most positive impairments.
The narrow differences among exposed individuals and their reduced number may explain why the number of impairments does not correlate with TCDD blood level, unlike in 2004.
